Total alkaloids of sophorea alopecuroides-induced down-regulation of acrab-tolc efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant escherichia coli isolates

Phytotherapy Research

Volumn 26, Issue 11, 2012, Pages 1637-1643

  Zhou, Xuezhang ^a,b   Jia, Fang ^b,c   Liu, Xiaoming ^a,b   Wang, Yujiong ^a,b  

^a Key Lab of the Min of Educ for the Conserv and Utiliz of Spec Biol Resources of Western China   (China)

^b NINGXIA UNIVERSITY   (China)

^c Hetao College   (China)

Author keywords

AcrAB TolC; alkaloids; efflux pump; Escherichia coli; multidrug resistance; Sophorea alopecuroides

Indexed keywords

ALKALOID; AMIKACIN; AMPICILLIN; CEFOTAXIME; CIPROFLOXACIN;

ACRA GENE; ACRB GENE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG POTENTIATION; DRUG SCREENING; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MULTIDRUG RESISTANCE; NONHUMAN; PHYTOCHEMISTRY; PLANT SEED; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOPHORA; SOPHOREA ALOPECIA; TOLC GENE; UPREGULATION;

ALKALOIDS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; SOPHORA;

ESCHERICHIA COLI;

EID: 84867845651     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4623     Document Type: Article

References (46)

1. Atta-Ur-Rahman A, Choudhary MI, Parvez K, et al,. 2000. Quinolizidine alkaloids from Sophora alopecuroides. J Nat Prod 63: 190-192.
2. Baker DD, Alvi KA,. 2004. Small-molecule natural products: new structures, new activities. Curr Opin Biotechnol 15: 576-583.
3. Baker DD, Chu M, Oza U, Rajgarhia V,. 2007. The value of natural products to future pharmaceutical discovery. Nat Prod Rep 24: 1225-1244.
4. Bush K, Jacoby GA,. 2010. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 54: 969-976.
5. Cha JD, Jeong MR, Jeong SI, Lee KY,. 2007. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens. J Microbiol Biotechnol 17: 858-864.
6. Cha JD, Moon SE, Kim JY, Jung EK, Lee YS,. 2009. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus. Phytother Res 23: 1326-1331.
7. CLSI. 2005. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute 15th Informational Supplement: M100-S115.
8. Dai HF, Gan YJ, Que DM, Wu J, Wen ZC, Mei WL,. 2009. A new cytotoxic 19-nor-cardenolide from the latex of Antiaris toxicaria. Molecules 14: 3694-3699.
9. Fakhimi A, Iranshahi M, Emami SA, Amin-Ar-Ramimeh E, Zarrini G, Shahverdi AR,. 2006. Sophora flavanone G from Sophora pachycarpa enhanced the antibacterial activity of gentamycin against Staphylococcus aureus. Z Naturforsch C 61: 769-772.
10. Hemaiswarya S, Kruthiventi AK, Doble M,. 2008. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15: 639-652.
11. Hirakawa H, Takumi-Kobayashi A, Theisen U, Hirata T, Nishino K, Yamaguchi A,. 2008. AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli. J Bacteriol 190: 6276-6279.
12. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA,. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61: 46-53.
13. Kobayashi I, Muraoka H, Saika T, Nishida M, Fujioka T, Nasu M,. 2004. Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates. J Med Microbiol 53: 403-406.
14. Leung ET, Ho PL, Yuen KY, et al,. 2006. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 50: 1075-1078.
15. Liu XJ, Cao MA, Li WH, Shen CS, Yan SQ, Yuan CS,. 2010. Alkaloids from Sophora flavescens Aition. Fitoterapia 81: 524-527.
16. Loske C, Neumann A, Cunningham AM, et al,. 1998. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105: 1005-1015.
17. Ma XM, Bao G, Wan JM, et al,. 2007. Therapeutic effects of Sophora moorcroftiana alkaloids in combination with albendazole in mice experimentally infected with protoscolices of Echinococcus granulosus. Braz J Med Biol Res 40: 1403-1408.
18. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H,. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 44: 3441-3443.
19. Murakami S,. 2008. Multidrug efflux transporter, AcrB - the pumping mechanism. Curr Opin Struct Biol 18: 459-465.
20. Neyfakh AA, Bidnenko VE, Chen LB,. 1991. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 88: 4781-4785.
21. Nikaido H,. 1996. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 178: 5853-5859.
22. Nikaido H, Pages JM,. 2011. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. DOI: 10.1111/j.1574-6976.2011.00290.x.
23. Nishino K, Nikaido E, Yamaguchi A,. 2009. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim Biophys Acta 1794: 834-843.
24. Olesky M, Zhao S, Rosenberg RL, Nicholas RA,. 2006. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J Bacteriol 188: 2300-2308.
25. Perez A, Canle D, Latasa C, et al,. 2007. Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. Antimicrob Agents Chemother 51: 3247-3253.
26. Petersen PJ, Labthavikul P, Jones CH, Bradford PA,. 2006. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57: 573-576.
27. Pfaffl MW,. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
28. Piddock LJ,. 2006a. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19: 382-402.
29. Piddock LJ,. 2006b. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4: 629-636.
30. Pitout JD,. 2008. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther 6: 657-669.
31. Poole K,. 2000. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44: 2233-2241.
32. Pos KM,. 2009. Trinity revealed: Stoichiometric complex assembly of a bacterial multidrug efflux pump. Proc Natl Acad Sci USA 106: 6893-6894.
33. Schroeder A, Mueller O, Stocker S, et al,. 2006. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
34. Sohn HY, Son KH, Kwon CS, Kwon GS, Kang SS,. 2004. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11: 666-672.
35. Stavri M, Piddock LJ, Gibbons S,. 2007. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59: 1247-1260.
36. Sulavik MC, Houseweart C, Cramer C, et al,. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45: 1126-1136.
37. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L,. 2011. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 55: 921-924.
38. Thorarensen A, Presley-Bodnar AL, Marotti KR, et al,. 2001. 3-Arylpiperidines as potentiators of existing antibacterial agents. Bioorg Med Chem Lett 11: 1903-1906.
39. Tikhonova EB, Zgurskaya HI,. 2004. AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem 279: 32116-32124.
40. Touze T, Eswaran J, Bokma E, Koronakis E, Hughes C, Koronakis V,. 2004. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system. Mol Microbiol 53: 697-706.
41. Yasufuku T, Shigemura K, Shirakawa T, et al,. 2011. Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients. J Clin Microbiol 49: 189-194.
42. Zhao G, Du W, Wei Y, Qin H, Wu X,. 2008. An HPLC method for the determination and pharmacokinetic study of lehmannine in rat plasma. Biomed Chromatogr 22: 1149-1154.
43. Zhao W, Song L, Deng H, Yao H,. 2009. Hydration, erosion, and release behavior of guar-based hydrophilic matrix tablets containing total alkaloids of Sophora alopecuroides. Drug Dev Ind Pharm 35: 594-602.
44. Zhou X, Zhao L, Liu X, et al,. 2011. Antimycobacterial and synergistic effects of 18beta-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis. Phytother Res. DOI: 10.1002/ptr.3536.
45. + Tregs and IL-10 in rats with experimental colitis. Am J Chin Med 38: 265-277.
46. Zhou Y, Wei Y, Liu H, Zhang G, Wu X,. 2010b. Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH-gradient method. AAPS PharmSciTech 11: 1350-1358.